Observational Study
Copyright ©The Author(s) 2017.
World J Diabetes. Jun 15, 2017; 8(6): 286-296
Published online Jun 15, 2017. doi: 10.4239/wjd.v8.i6.286
Figure 2
Figure 2 Numbers of participants with type 1 diabetes in the ancillary neurocognitive study (n = 108) who reported using lipid lowering and antihypertensive medications from parent study baseline (1986-1988) through time of cognitive assessment (2010-2012).